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HIV seroconversion among factory workers in Harare: who is
getting newly infected?
M T M BIZV O , * AS L A T IF , R M ACHEKA NO, W  M ACFARLAND, M T BA SSETT, S RAY,
D K ATZENSTEIN
Objective: Zimbabwe, like other countries in sub-Saharan Africa, is experiencing a rapidly growing HIV) 
AIDS epidemic. It is crucial to determine risk events and socio-demographic characteristics associated will 
incident infections in order to tailor prevention messages accordingly. A cohort was established amooj 
factory workers with the objectives of estimating HIV incidence, seroprevalence, correlates of infection and 
subsequently evaluating the impact of prevention interventions.
Setting: 40 factories in Harare, Zimbabwe.
Design and Methods: HIV seroincidence (total new infections over person time (years) follow up] wa 
estimated in a longitudinal cohort of male factory workers before and during a randomised peer educatki 
intervention. Correlates of seroconversion were identified using Cox regression analysis.
Results: Of 2 992 subjects enrolled there were 129 seroconversions during 1993 to 1996 follow up, yieldinj 
a 2.96 per 100 person year (PY) seroconversion incidence (95%CI = 2.47to 3.52). Reporting a genital uka 
during follow up (Hazard ratio [HR] = 4.9, p-0.001) having multiple sexual partners (HR=1.9, p=0.04) 
having a urethral discharge (HR = 2.1, p=0.001), being single (HR = 2.3, p=0.001), widowed or marriedbui 
not residing with wife were independent factors significantly associated with risk o f HIV seroconversion. 
Conclusions: Incidence of HIV identified in this economically productive sector is unacceptably high, and, 
disturbingly, is increasing in some age groups. Although the impact of the present intervention remains tobt 
evaluated, the high incidence of HIV infection, points to the need for a more aggressive prevention effortii 
the general population.
Introduction
It was estimated that by the of 1996 more than 8.4 million 
AIDS cases had occurred worldwide.1 Because of the long 
and variable duration between infection with the human 
immunodeficiency virus (HIV) and the ultimate development 
of AIDS, a more useful indication of current trends in the 
epidemic is the number of new infections with HIV.
Twenty eight million people from 190 countries across the 
world were HIV positive by mid 1996.JComposed of distinct 
epidemics, each with its own features, degree and extent, the 
pandemic has had a disproportionately severe impact on the 
developing world.
Despite wide information on HIV prevention, 3.1 miUia 
new infections occurred during 19961. Up to 93% of the HIV 
infections recorded in 1996 were from developing countries 
with 68% from sub-Saharan Africa.2 Developing countries, 
who have weaker economic structures, continue to bear tlx 
greatest burden of HIV infections. HIV infection appeaistt 
be spreading much faster in southern Africa than anywhen 
else.3
The World Health Organisation4 has observed that tlx 
global epicentre of HIV infection had moved from Easten 
Africa to Southern Africa. According to the 1996 UNAID5 
report, the six most severely HIV affected countries are il 
Southern Africa (Botswana, 18%; Zambia and Zimbabwe,
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17.4%; Uganda, 14.5%; Malawi, 13.6% and South Africa, 
10.4% with one of the fastest growing incidence.2 
In Zimbabwe, trends are emerging on the course of the 
epidemic. Initial infections and risk behaviour were recorded 
among identifiable high risk groups such as sex workers, 
truck drivers and army personnel.5 6 Current data suggest 
infection within the general population where a sexual partner 
has engaged in high risk sexual activity. Despite reasonably 
high levels of awareness of AIDS, adult infections have risen 
in the general populations in both rural and urban communities. 
Prevalence was estimated to be 18% in 1990 and 30.2% in 
19957 in urban pregnant women and 19 % among male factory 
workers.' Antenatal clinics in rural settings have recorded 
HIV-1 prevalence of 24% in Manicaland province9 and up to 
47% in Masvingo province (Unpublished observation). 
Sentinel surveillance data on both HIV incidence and 
prevalence is important for monitoring the course of the 
epidemic over time. Findings of an upward trend lend support 
10 the urgency of intervention programmes with multiple 
tategies. They also highlight the need to extend prevention 
programmes to vulnerable populations. Information on new 
infections Should assist in the continued refinement of 
Strategies towards HIV prevention.
The Zimbabwe AIDS Prevention Project (ZAPP).has 
followed a cohort of factory workers since 1993, to describe 
the epidemiology of HIV infection, and to institute and 
monitor the impact of selected interventions. In this report we 
present the overall HIV incidence over time along with risk 
factors of seroconversion in the cohort between 1993 and 
1996.
Materials and Methods
Study Subjects, Recruitm ent, and Follow up.
Subjects were participants in the Z APP on longitudinal follow 
up.ZAPP was established with the objective of estimating 
HIV sero-incidence, determining the epidemiological and 
biological determinants of HIV infection, counselling and 
evaluating AIDS prevention interventions based in the 
workplace. Subjects were recruited from 40 factories beginning 
in March 1993. Recruitment for the study occurred in 
conjunction with blood donor recruitment campaigns 
conducted by the National Blood Transfusion Service (NBTS). 
Acceptance for blood donation was not required for 
pvticipation in the study. Participants included in the present 
analysis were men, employed, and residents of Harare for at 
least part of the year. We present in this paper HIV sero- 
incidence and behaviours independent of implementation of 
(randomized peer educator-based workplace intervention. 
Subjects gave written informed consent, and were then 
iderviewed and tested for HIV. The only direct service 
offered at recruitment was HIV post test counselling. The 
project provided condoms, a counselling and testing service 
for partners, and free STD treatment to enrolled subjects and 
partners. These benefits were offered on an individual basis 
liter voluntary consent and enrolment were completed.
Upon enrolment, each participant had blood drawn for HIV 
testing,received pre-test HIV counselling, and was interviewed 
ving a structured questionnaire. Condoms were offered at 
the end of the interview. All serological results and
questionnaire data were confidential and protected by 
computer coding systems. Results and post test counselling 
were available to participants at the project clinic site only. 
Individual test results and risk data were not made available 
to employers or to any on-site or referred employer health 
personnel. Furthermore, test results were filed in secure 
locked facilities separate from data collection forms.
Follow up of participants at the same factories occurred 
approximately every four to six months. Subjects who were 
HIV negative on enrolment and had at least one follow up 
HIV test were included in this analysis.
Survey Methods.
Subjects were interviewed using a structured questionnaire at 
enrolment and at each follow up visit. Putative risk factors for 
HIV seroconversion were based on risk factors for prevalent 
HIV infection10, on HIV risk factors determined in a case 
control study among factory blood donors in Zimbabwe5, and 
other established epidemiological features of HIV infection 
in Africa. Sociodemographic information collected on 
enrolment included age, marital status, residence of wife, 
education, and salary. HIV risk related questions included the 
number of different sex partners, whether subjects had 
girlfriends, whether subjects had exchanged money for sex, 
and STD history by syndrome type in the preceding year.
' Subjects were also asked whether they had visited a beer hall 
in the preceding week. At each follow up, subjects were asked 
the same risk related questions referring only to events 
occurring between visits. For example, subjects were asked 
about STD syndromes that had occurred since their last 
interview or if they had presented at a clinic for treatment. 
Condom use was measured as self reported frequency of use 
prior to enrolment.
HIV Testing.
Scrum samples were screened at entry and at each follow up 
visit for HIV specific antibodies using a third generation 
ELISA, the Abbott HIV-l/HIV-2 (Abbott Park, Illinois). 
Specimens reactive or indeterminate in the Abbott test were 
retested using a second, third generation ELIS A, the Enzygnost 
Anti-HIV 1/2 Plus (Behring, Marburg, Germany). Samples 
were considered HIV antibody positive when positive results 
were obtained from both ELISAassays. Indeterminate results 
in either assay or conflicting results between the two 
recombinant ELISA tests were resolved by Western Blot, the 
HIV Blot 2.2 (Diagnostic Biotechnology, Singapore), HIV 
cultures, and polymerase chain reaction amplification of 
specific gag gene DNA.
Statistical M ethods.
HIV sero-incidence was calculated as the number of 
seroconversions divided by the total person-time under 
observation. Person-time was calculated as the interval 
between enrolment and the most recent follow up visit for 
subjects who remained HIV negative. For subjects who 
seroconverted, person-time was calculated as the interval 
between enrolment (last HIV negative test) and the first HIV 
positive test within the follow up period. Confidence intervals 
were calculatedasexactlimitsassumingaPoisson distribution 
of seroconversions. Bivariate and multivariate associations 
with HIV seroconversion were estimated using Cox regression 
analysis.
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Results
Between March 1993 and December 1996, 3 005 subjects 
were enrolled and results on HIV were available on 2 992 with 
total person years follow up of 4 353.35. A total of 129 male 
HIV seroconverters were identified in the ZAPP cohort with 
a mean age (years) of 31±9.7 (SD) and an overall 
seroconversion incidence of 2.96 per 100 PY (95%CI=2.5 to 
3.5%). HIV prevalence was 19.7%. The sociodemographic 
factors associated with risk for seroconversion are shown in 
Table I. Men aged below 25 years had the highest 
seroconversion incidence, although seroconversion was 
observed for all age groups. Men who were single (Hazard 
ratio 6.0), and widowed/separated/divorced showed the highest 
seroconversion incidence of 3.9 per 100 PY and 6.0 per 100 
PY respectively, as shown in Table I.
There was an increase in HIV seroconversion incidence 
over time for all groups, even among those aged 30 years and 
above. Between 1994 and 1995 the HIV incidence appeared 
stable, with 1996 showing the highest seroconversion 
incidence for all age groups especially those aged 31 to 39 
years, as shown in Figure I.
In a m ultivariate model, sociodemographic factors 
associated with HIV seroconversion were being single (Hazard 
ratio 2.3, p=0.001), being widowed (Hazard ratio 9.2, p=0.029), 
married but not residing with wife (Hazard ratio 1.7, p=0.033) 
and being aged 35 to 39 years (Hazard ratio 1.7, p=0.034).
The risk of HIV seroconversion was analysed further 
according to behavioural characteristics and history of sex ually
Figure 1: HIV incidence by age group over time (adjusts 
for change in age with calendar time).
transmitted disease (STDs) during follow up. Signific 
men reporting multiple sex partners, paying for sex I 
condom use were more likely to seroconvert during fol 
up.
Having had an STD during follow up (Hazard ratio=3i 
a genital ulcer (Hazard ratio = 4.3) or a urethral dischqj 
(Hazard ratio = 8.5) were significantly associated with Ik 
risk of seroconversion. Table II outlines the STDandbehavin 
characteristics associated with the risk of HIV incidence 
after adjusting for those reported after seroconversion.
In a multivariate model, reporting of a genital ulcer durim 
follow up, urethral dischargcand having multiple sex paflM 
were independently associated with the risk of IN
Table I: Risk factors fo r  serocoversion per 100 person years (PY) in a male factory worker cohort. Hazard Ratio and 95% 
Confidence Intervals (Cl).
Dem ographic characte ris tics S eroconvers ion* To ta l = 129 D is tribu tion  (%) HIV Sero-incidence pe r 100 py  (95% C l) Hazard Ratio (9S%Cf
Age (years)
>19 8 6 2 4.1 (1.8-8.2) 2.7
2 0 -2 4 50 38.8 3 .9 (2  9 -51) 2.6
2 5 -2 9 18 14.0 2.2 (1.3-3 5) 1.5
3 0 -3 4 16 124 2.6(1.5-4.2) 1.7
3 5 -3 9 23 17.8 3.8 (2.4-58) 2.5
4 0 -4 9 9 6 9 1.5(07-2.8 ) referent
50 + 5 3 9 2 .2 (0 7 -5 1 ) 1.5
Overall 129 100
Marita l S ta tus
Single 55 4 2 6 3.9 (2.9-5.1) 2.2
Widowed/
Separated/
Divorced 4 3.1 6.0(1.6-15.3) 3.3
Married, reside
together 27 2 0 9 1.8(1 2-2.6) referent
Married, reside
apart 43 33 3 3.2 (2 3-4.3) 1.8
Education
None 1 0 8 3.2(0.1-16.7) 0.8
Grade 1 - 7 24 18.6 2.7 (1.7-4.1) 0.7
Form 1 - 4 89 6 9 0 2.9 (2.4-3 6) 0.8
Above form 4 15 116 3.8 (2.1-6.2) referent
; Table II: STD and behavioural characteristics and their bivariate associations with HIV seroconversion incidence. Person 
| leers follow up (PY) and Hazard Ratio (HR), adjustment for reported STDs after conversion. .
(. Seroconversiont
l IIDA Behavioural characteriatles (Total ■ 129) PY
%  STD during follow up
yes 75 457
no 34 3696
i ta W  ulcer during follow up
• yes 106 184
no 23 4170
M M  discharge during follow up
yes 117 164
no 12 4190
Md tor tax during follow up
yes 106 583
no 23 3771
M l lien one partner during follow up
yes 74 1571
no 55 2783
Condom use during follow up
yes 97 640
no 32 2130
Distribution (%)
HIV ssro-bicidence
p*r100P Y (95% C I) Hazard Ratio
73.6 7.4(5.2- 0.4) 3.1 ‘
26.4 4.0(1.97-2.98) 1
82.2 12.5(7.9-18.8) 4.9*
17.8 2.5(2.1-3,1) 1
90.7 7.3(3.8-12.8) 2.7*
9.3 2.8(2.3-3,4) 1
62.2 5.0(3.3-7.2) 1.9*
17.8 2.7(2.2-3.2) 1
57.4 4.7(37-5.9) 2.4*
42.6 2.0(1.5-2.6) 1
75.2 3.8(3.1-47) 2.2*
24.8 17(1.2-2.5) 1
SID — Sexually transmitted disease.
Pf — Parson yean follow up.
MY -  Human Immunodeficiency virus. 
HI -  Hazard ratio.
Table III: Multivariate analysis o f risk factors fo r  IllV  
seroconversion in the male factory worker cohort, 1993 to 
1996. Hazard Ratio and 95% Confidence Interval.
Ouncterlstlcs Hazard Ratio 95% Cl p-value
Genital ulcer during follow up 3.8 2.4-6.1 <0.0001
Urethral discharge during follow up 2.1 1.3-27 0.001
HiNple sex partners during follow up 1.9 1.0-3.5 0.042
Chmcterietics Hazard Ratio p-valua
Single 2.3 0.001
«ga:35-39 1.7 0.034
Harried, not residing with wife 1.7 0.033
Widowed 9.2 0.029
seroconversion. Table III summarizes independent predictors 
of seroconversion in the cohort.
Discussion
A strong correlation was found between the risk of HIV 
seroconversion and reporting a genital ulcer during follow up, 
being single or married but not residing with wife marital 
situation, as well as reporting a urethral discharge, having 
multiple sexual partners, being widowed or being in a certain 
Sgegroups. The identified risk factors for seroconversion are 
similar to those reported in prevalent HIV infection in our 
population.5 At this time in the course of the epidemic, it is 
important to relate this data to the HIV prevention efforts in 
Ike general population. It appears that the same risk factors
identified among those infected at baseline10 or in the general 
population5 remain very similar to those identified in incident 
infections in the present report. In addition, the incidence 
does not appear to be abating over time.
In si mplistic terms, given the reality of AIDS and prevention 
messages, one would expect that we would be observing 
fewer new infections in the late 1990s than was the case in the 
‘ 1980s or early 1990. The younger, and yet most productive 
age groups remain most vulnerable. There appeared an increase 
in HIV seroincidence overtime for all age groups. The 
incidence does not appear stable or declining over time. It was 
particularly striking that the men aged 30 years or more are 
not moving out of high risk. These data pose some challenges 
to HIV prevention and control efforts. The challenge extends 
from programme managers to health and economic planners, 
educationists, researchers, politicians, the private and public 
sectors. To what extent are our programmes and prevention 
efforts being responsive to the problem of HIV in Zimbabwe? 
What underlying factors impede or promote behaviourchange? 
Which interventions are likely to offer the best hope?
Although in Zimbabwe, general awareness about AIDS is 
high, limited information is available to show the impact of 
increased awareness on the course of the epidemic. What are 
the reasons for the big knowledge-practice gap in Zimbabwe, 
or elsewhere? Most interventions have also focused on areas 
most hit by the epidemic and among high risk groups. These 
results show that high risk sexual behaviour remains common 
among men in the general worker population. Furthermore, 
although increasing general awareness and knowledge about 
• HIV/AIDS is essential, such knowledge alone is not enough 
to ensure the desired changes in sexual behaviour. Further 
studies on innovative strategies should provide detailed
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information on what is likely to bring about desired results.
Studies on sexual behaviour elsewhere in sub-Saharan 
African report that men are more likely to have multiple 
sexual partners than women.11 This suggests that men in the 
region could be an important source of spread of HIV. In a 
recent study in Dar-es-Salaaml2, a male partner’s sexual 
behaviour was a major predictor of HIV infection among 
women not reporting high risk sexual behaviour.
AIDS is taking a toll in reducing quality of life and life 
expectancy in Africa.13 AIDS is now believed to be the 
leading cause of adult death between the ages of 15 and 39 in 
most countries in southern Africa.13
Men in settings such as workplaces, should be targeted on 
an ongoing basis for HIV prevention programmes. Innovative 
approaches could include on-site STD prevention and control 
programmes. This could take the form of selected mass STD 
treatment based on reported high risk behaviour.
There is epidemiological and biological evidence which 
suggests that STDs facilitate transmission of HIV and are 
major contributors to the magnitude of the epidemic in sub- 
Saharan Africa.14 A substantial proportion of HIV infections 
could be prevented by effective STD control programmes. In 
Mwanza, Tanzania, Grosskurth and co-workers16 reduced 
HIV incidence by 40% through improved STD treatment.
In the male adult population in  Harare, STDs remain the 
most common medical complaint. Effective STD prevention 
and control programmes should be institutedat various settings 
such as the workplace, the growth point and social outlets in 
the community.
Finally, the AIDS crisis needs to be seen as having adverse 
implications for development as more resources and effort 
need to go into prevention. Further research in the socio- 
behavioural domain needs to define what works and the 
sustained effectiveness of different interventions.
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